Press release
Cancer Gene Therapy Market Is Estimated To Reach $2,082 Million By 2023
For More Info, Get Sample : http://bit.ly/2j8zzeQ
The rise in prevalence of cancer, benefits of cancer gene therapy over conventional cancer therapies, and the advancement in this field are the major factors that drive the market growth. In addition, increase in government support, ethical acceptance of gene therapy for cancer treatment, and rise in biotechnological funding encourage the R&D activities for cancer gene therapy and thus fuel the growth of the cancer gene therapy market. However, high cost associated with the treatment and unwanted immune responses are expected to restrain the market growth.
The global cancer gene therapy market is segmented based on therapy, end user, and geography. Based on therapy, it is categorized into gene induced immunotherapy (delivery of cytokines gene and delivery of tumor antigen gene), oncolytic virotherapy (adenovirus, lentivirus, retro virus, adeno associated virus, herpes simplex virus, alpha virus, vaccinia virus, simian virus, and others), and gene transfer (naked plasmid vector, electroporation, sonoportion, magnetofection, and gene gun). Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
• The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
• In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
• The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY PLAYERS PROFILED
• Adaptimmune
• GlaxoSmithKline
• Bluebird bio, Inc.
• Merck
• Celgene
• Shanghai Sunway Biotech
• BioCancell
• Shenzhen SiBiono GeneTech
• SynerGene Therapeutics
• OncoGenex Pharmaceuticals
Enquire About Report : http://bit.ly/2zCSCVJ
KEY MARKET SEGMENTS
By Therapy
• Gene Induced Immunotherapy
• Delivery of Cytokines Gene
• Delivery of Tumor Antigen Gene
• Oncolytic Virotherapy
• Adenovirus
• Lentivirus
• Retro Virus
• Adeno Associated Virus
• Herpes Simplex Virus
• Alpha Virus
• Vaccinia Virus
• Simian Virus
• Others
• Gene Transfer
• Naked/Plasmid Vectors
• Electroporation
• Sonoportion
• Magnetofection
• Gene Gun
By End User
• Hospitals
• Diagnostics Centers
• Research Institutes
Also Request For Discount : http://bit.ly/2hQznxk
By Region
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Republic of South Africa
• Saudi Arabia
• Rest of LAMEA
The other players of the cancer gene therapy market include (companies not profiled in the report):
• Cell Genesys
• Advantagene
• GenVec
• BioCancell
• Celgene and Epeius Biotechnologies
• Introgen Therapeutics
• Ziopharm Oncology
• Shenzhen SiBiono GeneTech
• Genelux Corporation
• Altor Bioscience
Table Of Content
• CHAPTER 1 INTRODUCTION
• CHAPTER 2 EXECUTIVE SUMMARY
• CHAPTER 3 MARKET OVERVIEW
• CHAPTER 4 CANCER GENE THERAPY MARKET, BY THERAPY
• CHAPTER 5 CANCER GENE THERAPY MARKET, BY GEOGRAPHY
• CHAPTER 6 COMPANY PROFILES
About Us
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.
Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Gene Therapy Market Is Estimated To Reach $2,082 Million By 2023 here
News-ID: 806070 • Views: …
More Releases from Research Beam Market
Blood Plasma Derivatives Market Growing With $44,333 Million At A CAGR of 9.3% F …
Blood plasma is liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains the blood pressure and helps in exchange of important minerals such as sodium and potassium to maintain the pH balance in the body. Plasma derivatives are products that are manufactured from human plasma by plasma fractionation techniques. These derivatives include albumin, factor…
Holter ECG Monitoring Market Growing $418.3 Million By 2023
Holter monitors are devices that allow prolonged monitoring of heart rhythm from a few days to several months, enabling the detection of infrequent arrhythmias in patients. In addition, holter monitors help identify ventricular tachycardia (VT) in patients with recognized risk of sudden cardiac death. Portability of holter monitors significantly propel the market growth as they can be easily worn by the patients to record heart activity for a certain period…
Intermittent Catheters Market Reach $2,950.7 Million By 2023
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are…
Continuous Glucose Monitoring Systems Market Registering A CAGR Of 22.9% By 2024
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in…
More Releases for Gene
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Gene Editing Market : A Market Study On Gene Editing And Cancer Therapy Techniqu …
Global Gene Editing Market
Precision Business Insights (PBI) in its report titled “Global Gene Editing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Gene editing or Genome editing is…
Direct-to-consumer Genetic Testing Market: Top Players - Gene By Gene, MyHeritag …
Latest industry research report on: Global and United States Direct-to-consumer Genetic Testing Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report studies the Direct-to-consumer Genetic Testing market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Direct-to-consumer Genetic Testing market by product…
